戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  morbidity, and vaccination is the preferred preventive strategy.
2 rmined, as does any potential benefit of any preventive strategy.
3 haps anticoagulation should be the preferred preventive strategy.
4  hyperimmune globulin may provide additional preventive strategies.
5 ries is underemphasized and not prominent in preventive strategies.
6 ics and delays implementation of appropriate preventive strategies.
7 dictors of AF is therefore necessary to plan preventive strategies.
8 asing public health burden and thus need for preventive strategies.
9 rs is required in order to move forward with preventive strategies.
10 sses that lead to loss of vision may lead to preventive strategies.
11  limiting the development of therapeutic and preventive strategies.
12 n the absence of effective implementation of preventive strategies.
13 ious risk in transfusion despite the current preventive strategies.
14 tive effectiveness and cost-effectiveness of preventive strategies.
15 hogenesis could reveal novel therapeutic and preventive strategies.
16 arify preclinical disease, and screening and preventive strategies.
17 an provide important insights into effective preventive strategies.
18 , multicentre collaborations may help inform preventive strategies.
19 leprosy reactions may have a major impact on preventive strategies.
20 cation and disease would help refine current preventive strategies.
21 s and identify patients who may benefit from preventive strategies.
22 at may benefit from more aggressive or novel preventive strategies.
23  the rational development of therapeutic and preventive strategies.
24 erlying this association in order to develop preventive strategies.
25 lignancies and even guide avenues for future preventive strategies.
26 es may promote the development of new cancer preventive strategies.
27 ntion and may promote the development of new preventive strategies.
28 hanisms, no effective therapy, and no proven preventive strategies.
29 g potential groups of interest, the focus of preventive strategies.
30 n about the causes of CP could help identify preventive strategies.
31 worldwide has resulted in an urgent need for preventive strategies.
32 d for the development of BCC and SCC and use preventive strategies.
33 e disease should lead to new therapeutic and preventive strategies.
34 and to discuss the controversies surrounding preventive strategies.
35 odel to study genital herpes and to evaluate preventive strategies.
36 pproaches and thus contribute to appropriate preventive strategies.
37 tal heart defects that would enhance current preventive strategies.
38 isk of progression will allow development of preventive strategies.
39  evaluating cancer risk and in the design of preventive strategies.
40 ntation is highly needed to establish guided preventive strategies.
41  technology and potentially locally directed preventive strategies.
42 kin, is crucial for directing therapeutic or preventive strategies.
43 iabetes and may lead to development of novel preventive strategies.
44 dentify patients who benefit from aggressive preventive strategies.
45 uch events among outpatients and to identify preventive strategies.
46 d upper cost limit considered acceptable for preventive strategies.
47 ll delineated, thus hampering development of preventive strategies.
48 ning risk factors for disease and developing preventive strategies.
49 ctors for GDM is needed to identify possible preventive strategies.
50 athogenesis and suggests new therapeutic and preventive strategies.
51 redistribution will ultimately help optimize preventive strategies.
52 isk for developing nosocomial infections for preventive strategies.
53 erspectives for the development of effective preventive strategies.
54 needed to help define future therapeutic and preventive strategies.
55  CKD and liver fibrosis who may benefit from preventive strategies.
56 iated factors may help in the development of preventive strategies.
57  with potentially important implications for preventive strategies.
58 athways, and targets for novel therapies and preventive strategies.
59 inical practice to guide early detection and preventive strategies.
60 ould influence treatment recommendations for preventive strategies.
61 eeded to support the development of improved preventive strategies.
62 tion of AKI is crucial in order to implement preventive strategies.
63 t failure (HF) may provide a basis for novel preventive strategies.
64 our understanding of pathogenesis and inform preventive strategies.
65 need for better influenza vaccines and other preventive strategies.
66 ating this setting as a potential target for preventive strategies.
67 sults suggest new possibilities for targeted preventive strategies.
68 t also for the development of diagnostic and preventive strategies.
69  for developing early melanoma detection and preventive strategies.
70 ct early preclinical conditions and initiate preventive strategies.
71 ogenesis and may present a target for future preventive strategies.
72 portant for women and caregivers considering preventive strategies.
73  benefits and risks when combined with other preventive strategies.
74 mission models, which might influence future preventive strategies.
75 in unclear, which hinders the development of preventive strategies.
76 in low- and middle-income countries to guide preventive strategies.
77 have possible utility for the development of preventive strategies.
78 rgic disease who may benefit from early life preventive strategies.
79 colon carcinogenesis will be key to defining preventive strategies.
80 VE, providing possible guidance for tailored preventive strategies.
81 o boost utilization of primary and secondary preventive strategies.
82 s under which risk information might enhance preventive strategies.
83 est, highlighting the need for complementary preventive strategies.
84       (4) Who can do what to implement these preventive strategies?
85          After the initial investment in the preventive strategy, 1 USD invested in the routine strat
86 for the development of novel therapeutic and preventive strategies against E. faecalis and beyond.
87  potential involvement in the development of preventive strategies against HIV-1 and other sexually t
88                     Until safe and effective preventive strategies against infarct recurrence are dis
89                                              Preventive strategies against knee osteoarthritis (OA) r
90 ningitis and may help in designing effective preventive strategies against this deadly disease.
91 h and contribute to the development of novel preventive strategies against ticks and tick-transmitted
92 rative cholangiography is not effective as a preventive strategy against common duct injury during ch
93                              Therefore, as a preventive strategy against endemic as well as pandemic
94 ng pregnancy and lactation is a useful early preventive strategy against obesity at preschool age.
95                                              Preventive strategies aimed at reducing assault and fall
96 pulations for screening interventions and/or preventive strategies aimed at the multigene products or
97 f this analysis of the long-term benefits of preventive strategies among BRCA1/2-positive women.
98 ary artery calcium (CAC) testing for guiding preventive strategies among women at low cardiovascular
99 lled studies have shown the efficacy of new, preventive strategies and debates about such approaches
100                                      Despite preventive strategies and increased awareness, a high in
101 rved in this study will direct the design of preventive strategies and inform CUA pathobiology.
102 ith thyroid dysfunction amenable to specific preventive strategies and interventional therapies relat
103 ant impact of HAP on patient outcomes, early preventive strategies and interventions to reduce HAP sh
104 eded in order to identify the most effective preventive strategies and most predictive vascular risk
105 , with possible implications for identifying preventive strategies and pathogenic mechanisms in autis
106 , with possible implications for identifying preventive strategies and pathogenic mechanisms in schiz
107 patterns can help to elucidate the impact of preventive strategies and public health policies.
108      If physicians are to develop meaningful preventive strategies and specific therapies for tumors
109 chanistic studies, the implementation of new preventive strategies and the discovery of novel treatme
110 es to intestinal health should lead to novel preventive strategies and therapies for a variety of gas
111 ed to further assess the benefits of primary preventive strategies and therapies.
112 bal research efforts are needed to establish preventive strategies and treatments for the various typ
113  cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algo
114 ating effects of AKI and provide guidance on preventive strategies, and early recognition and managem
115 nicians to decide further biomarker testing, preventive strategies, and follow-up planning in patient
116  investigation into predisposing conditions, preventive strategies, and more effective therapies.
117 ving the way to innovative diagnostic tools, preventive strategies, and therapeutic interventions alt
118 e for the development of future diagnostics, preventive strategies, and therapy for cardiovascular di
119                 Data on population, methods, preventive strategy, and outcome (measured as catheter-r
120 agnostic methods; appropriate therapeutic or preventive strategies; and continued surveillance for no
121 are killed each year by diarrhoeal diseases; preventive strategies appropriate for developing countri
122 ent renal allograft thrombosis, although new preventive strategies are coming.
123 high-risk patients, contrast medium use, and preventive strategies are discussed in this report.
124 ceipt of cord blood; the outcome is poor and preventive strategies are ineffective.
125    Its mechanisms however remain unclear and preventive strategies are lacking.
126 lth problem worldwide, and new therapies and preventive strategies are necessary for controlling the
127                        Novel therapeutic and preventive strategies are needed to contain the HIV-1 ep
128                                      Primary preventive strategies are needed to reduce SCD incidence
129 acquired acute kidney injury (AKI), targeted preventive strategies are not available.
130                                              Preventive strategies are therefore urgently needed, esp
131                                           If preventive strategies are to achieve their full potentia
132    The underlying mechanisms and efficacy of preventive strategies are unknown.
133  most common cause of cancer death in women, preventive strategies are urgently needed.
134  most common cause of cancer death in women, preventive strategies are urgently needed.
135  and the implementation of early oral health preventive strategies are warranted to reduce the burden
136 rview of computer network security risks and preventive strategies as they pertain to the radiology e
137 is and provide an opportunity for additional preventive strategies, as well as measures of efficacy i
138                             Aflibercept as a preventive strategy, as used in this trial, may not be g
139 nt pneumonia is common and more attention to preventive strategies at discharge and closer follow-up
140                                The KE-1 diet preventive strategy attenuated development of left ventr
141 d the requirement of designing area-specific preventive strategies based on geographic and meteorolog
142 stress the need for developing effective AKI preventive strategies beyond minimization of contrast do
143 and management have been the cornerstones of preventive strategies but are constrained by less than d
144  region for stroke-related interventions and preventive strategies by global healthcare authorities a
145 nt stroke need to be investigated further so preventive strategies can be formulated.
146                                      Several preventive strategies can be incorporated in surgical pr
147                                     Adequate preventive strategies can crumb the prevalence of allerg
148 se of glucocorticoids and the application of preventive strategies can minimize these adverse effects
149 uired to ascertain whether implementation of preventive strategies can offset the predicted rise in s
150                             We recorded that preventive strategies could result in a 2-year gain in l
151 g at intermediate risk, for whom the optimal preventive strategy could be more precise.
152                          Despite advances in preventive strategies, cytomegalovirus (CMV) infection r
153                  These findings suggest that preventive strategies developed for common chronic disea
154 anding its pathogenesis and, thus, improving preventive strategies, diagnostic tools, and therapies.
155 ntroduction of epidemiologically appropriate preventive strategies difficult.
156                                              Preventive strategies directed toward earlier and more a
157    Areas covered included diagnosis, general preventive strategies (e.g., vaccinations, sun avoidance
158 ort decision-making on the timing of CF as a preventive strategy, early introduction of specific food
159                              Attitude toward preventive strategy (encourage, neutral, discourage); le
160 ation of the fruits of research has advanced preventive strategies, enhanced clinical outcomes in aff
161                                              Preventive strategies exist and when admitted monitoring
162                                              Preventive strategies exist in the areas of social viole
163  (HF) is a prevalent and deadly disease, and preventive strategies focused on at-risk individuals are
164                                       Future preventive strategies focused on improving cardiometabol
165 ells and early onset atopy could lead to new preventive strategies for allergic diseases.
166 chanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease.
167 for diagnostic-specific therapies as well as preventive strategies for anthracycline toxicity and mus
168 ing the efficacy of innovative therapies and preventive strategies for anxiety disorders as a functio
169 ies of BPD prevention; however, most current preventive strategies for BPD focus on respiratory manag
170 a cost-effectiveness analysis of alternative preventive strategies for CM.
171 fectiveness of currently available effective preventive strategies for contrast-induced acute kidney
172                                  To optimize preventive strategies for coronary heart disease (CHD),
173                This approach may lead to new preventive strategies for CP.
174 may be integrated into current multi-faceted preventive strategies for curbing the epidemic of diabet
175 adjusted comparisons in research and improve preventive strategies for high-risk patients.
176 essments, and targeted LTSS may be important preventive strategies for maintaining independence in vi
177                                      Today's preventive strategies for nosocomial sepsis focus on aug
178                                              Preventive strategies for optimal communication and incl
179 he development of personalized treatment and preventive strategies for pathogenic infections.
180 s warranted to clarify its role and optimize preventive strategies for PEP.
181                          Early detection and preventive strategies for PVD may decrease amputation ra
182 udies are warranted to determine the optimal preventive strategies for reducing bloodstream infection
183                              Introduction of preventive strategies for reducing subsequent harm after
184                    The Early use of eXisting PREventive Strategies for Stroke (EXPRESS) study showed
185                                  Research in preventive strategies for the treatment of gout is neede
186 arteriolopathy (CUA) is necessary to develop preventive strategies for this morbid disease.
187 rly life might be beneficial and suggest new preventive strategies for wheezing and allergic diseases
188      Hydration alone was the least effective preventive strategy for CIAKI.
189 sing a safe micronutrient, LCAR, as a simple preventive strategy for iatrogenically induced ototoxici
190 proving sleep quality may thus represent one preventive strategy for lowering inflammatory status and
191 r interruptions to sitting time, a promising preventive strategy for metabolic diseases.
192 ment (ARE) signaling pathway is an important preventive strategy for normal cells against carcinogene
193 ests targeting of gap junction activity as a preventive strategy for obesity-associated endometrial c
194 ion could be a beneficial nonpharmacological preventive strategy for patients with hypertensive cardi
195 2 activity during AT exposure is a potential preventive strategy for post-AT psychopathologies includ
196 , as part of a molecular-targeted metastasis preventive strategy for the treatment of patients with H
197 e markers of viral replication are important preventive strategies, guiding immunosuppression reducti
198 ss considered important, including community preventive strategies, harm reduction interventions to r
199 es per 100,000 inhabitants, a cost-effective preventive strategy has been tested in this work by rede
200 ancer deaths in Zambia but, as elsewhere, no preventive strategies have been identified.
201                 The design of diagnostic and preventive strategies have been prevented by gaps in kno
202                                      Optimal preventive strategies have not been clearly defined.
203                                   Successful preventive strategies have recently been reported which
204 need to be allocated to design and implement preventive strategies (healthy lifestyles, modifications
205 Almost all noted the potential harms of each preventive strategy; however, the negative aspects of ta
206 agnoses but there are currently no effective preventive strategies, illustrating a need for chemoprev
207 toms and thus provide a rationale for future preventive strategies in high-risk groups.
208  (MD) may help inform more effective primary preventive strategies in high-risk populations.
209 lenging, with very limited implementation of preventive strategies in most parts of the world.
210 s link, the epidemiology of tuberculosis and preventive strategies in patients infected with HIV are
211       hsTnI may have a role in personalizing preventive strategies in patients with diabetes mellitus
212 d the risk of acute CIN and the influence of preventive strategies in patients with ST-segment-elevat
213 ad to more effective treatments and/or novel preventive strategies in RA.
214                                    Potential preventive strategies in the development of hepatocellul
215 targeted surveillance, as well as developing preventive strategies in the form of aggressive manageme
216 everal components may well lead to effective preventive strategies in the future, with positive impac
217                           The most important preventive strategies in the primary and secondary preve
218 till no consensus as to the value of primary preventive strategies in these conditions.
219 ther studies mainly regarding prediction and preventive strategies in this context.
220 r studies are needed to help optimize stroke preventive strategies in this high-risk group.
221 id in refining surveillance, counseling, and preventive strategies in this population.
222               CMV HIG was not supported as a preventive strategy in 2 randomized controlled trials, w
223 de decision making regarding the type of CMV preventive strategy in kidney transplantation.
224 -course nasal mupirocin could be a potential preventive strategy in male patients because it signific
225                                              Preventive strategies include the use of repetitive shor
226 g predictors of noncompliance and initiating preventive strategies, including education and support s
227 due to advancements in immunosuppression and preventive strategies, including pretransplant infectiou
228                      The surrogate effect of preventive strategies, including the challenge of the 40
229                                      Current preventive strategies, including the polysaccharide conj
230 eir potential to provide the basis for novel preventive strategies is warranted.
231                             At this time, a "preventive" strategy is evolving in which early aggressi
232                                    Effective preventive strategies likely offer the greatest and most
233                                      Because preventive strategies may not only be ineffective but ma
234                                              Preventive strategies must be implemented to minimize th
235                  BPs are well tolerated, but preventive strategies must be instituted to avoid renal
236                                     However, preventive strategies on a global scale might ultimately
237  understanding may provide a basis for novel preventive strategies or therapies for patients with thi
238 sis, was added to the HFHS diet, either as a preventive strategy or as a therapeutic intervention.
239 ti-SDF-1 antibody from postnatal day 1 to 7 (preventive strategy) or postnatal day 7 to 14 (therapeut
240                Moreover, these sensitization-preventive strategies promote bone marrow engraftment in
241 lished that assist with our understanding of preventive strategies, questioning the utility of prethe
242                                              Preventive strategies reducing the odds to develop cardi
243 mited influence on the outcome of AKI, and a preventive strategy remains the mainstay to attenuate it
244                                              Preventive strategies require a knowledge of risk factor
245                                              Preventive strategies require information about etiology
246                                Treatment and preventive strategies should be aimed at children in thi
247                          Mortality risks and preventive strategies should be discussed with patients
248 clinical guidelines should be considered and preventive strategies should be targeted at children and
249        The implementation of this multimodal preventive strategy should be considered in centers with
250            Longer-term outcomes are poor but preventive strategies show promise.
251                                         Both preventive strategies showed similar efficacy in prevent
252 ikelihood of mortality from STEMI and use of preventive strategies such as preprocedural intubation i
253       These recommendations cover diagnosis, preventive strategies such as prophylaxis and pre-emptiv
254                                     Although preventive strategies such as vaccination are important,
255 ill be enhanced by developing more effective preventive strategies (such as chest wall barriers) to a
256 okinetic and pharmacodynamic considerations, preventive strategies (such as prophylaxis in MDR and XD
257 ators and growth factors on the disease; (5) preventive strategies, such as anaerobic bacterial suppl
258 o tailor their prenatal management and adopt preventive strategies, such as low-dose aspirin.
259                                     Previous preventive strategies, such as prolonged exclusive breas
260   Lowering the number of CVD deaths requires preventive strategies targeted on the elderly.
261 V) rate of evolution is essential for cancer-preventive strategies targeting HPV.
262 ategies and focus on nonvaccine-based cancer preventive strategies targeting the immune system at the
263 ible individuals can result in the design of preventive strategies targeting the most "at risk" popul
264                        This review addresses preventive strategies that can be used to decrease the r
265  the prospective risk of disability, guiding preventive strategies that could attenuate the disableme
266 ted effects on lifetime risk of hypothetical preventive strategies that delay disease onset by 1, 2 a
267                                              Preventive strategies that delay disease onset with 1 to
268 on to recognition of depression, and also to preventive strategies that increase the patient's self-e
269 as well as in the identification of putative preventive strategies that may mitigate vascular complic
270                          Designing effective preventive strategies that people can apply during their
271              We conclude that in addition to preventive strategies, therapies based on bone morphogen
272  research is needed for better screening and preventive strategies to abrogate these toxic effects an
273 at may help develop novel therapeutic and/or preventive strategies to ameliorate pain in SCD.
274 ent population but will also help us develop preventive strategies to ameliorate patients' suffering
275  for further quality improvement efforts and preventive strategies to be utilized.
276 ent must focus on early diagnosis and robust preventive strategies to give them the best chance of op
277  review of the evidence concerning candidate preventive strategies to intervene on social determinant
278 sease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin ther
279 s initiative and supports the development of preventive strategies to mitigate environmental cancer r
280 ealth authorities may develop evidence-based preventive strategies to offer influenza vaccination in
281 ity to improve medical treatment and develop preventive strategies to preserve health.
282                   We need to further develop preventive strategies to reduce the burden of critical i
283 trition products that could become a part of preventive strategies to reduce the incidence of allergi
284 vention in this dysregulation may open a new preventive strategy to control early-life weight gain an
285 lipid supplementation with AA:DHA is a novel preventive strategy to decrease severe ROP in extremely
286 nity, can modulate neutrophil responses as a preventive strategy to mitigate the age-associated decli
287 ing at an alarming rate due to an inadequate preventive strategy to protect the lens from this protis
288 eness and efficiency in Ethiopia of standard preventive strategies used in high-transmission regions
289  AKI lacks effective therapeutic approaches, preventive strategies using preconditioning protocols, i
290             A more comprehensive, multimodal preventive strategy, using preoperative beta-blockers an
291  organism, and translational significance of preventive strategies was demonstrated in preclinical mo
292 y injury in critically ill adults and offers preventive strategies when appropriate.
293 high-risk patients, contrast medium use, and preventive strategies will be discussed in this article.
294                     Whether screening and/or preventive strategies will reduce the risk of ESKD in wo
295                              The recommended preventive strategies with the strongest supportive evid
296 S prophylaxis, several groups have adopted a preventive strategy with corticosteroids, especially for
297                               An emphasis on preventive strategies would therefore appear to be the m
298 prospective studies to demonstrate whether a preventive strategy would improve the outcome.
299                Xylitol is promoted in caries-preventive strategies, yet its effective dose range is u
300 epresent attractive targets for antimalarial preventive strategies, yet the mechanisms of parasite en

 
Page Top